RGC Stock Analysis
RG
Uncovered
Regencell Bioscience Holdings Ltd is uncovered by Eyestock quantitative analysis.
Market cap $B
0.076
Dividend yield
—
Shares outstanding
13.013 B
Regencell Bioscience Holdings Ltd. engages in the research, development, and commercialization of traditional Chinese medicine. The company employs 13 full-time employees The company went IPO on 2021-07-16. The firm launches three liquid based standardized TCM formulae candidates for mild, moderate and severe ADHD and ASD patients.
View Section: Eyestock Rating